Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Rheumatology Biologic Expertise Valued for COVID-19 Treatment Decisions

Catherine Kolonko  |  Issue: August 2020  |  May 18, 2020

“We’re doing a current review of the data, but the sense we are getting is that we’ve been able to prevent some major critical care disasters,” she says.

The Role of Fellows
Rheumatology fellows have been involved in many aspects of the effort to treat COVID-19 patients, including monitoring patient lab reports and, along with Dr. Torralba, advising primary medical teams about biologic drug recommendations.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Fellows conduct consultations via telemedicine, so they are not working at the patient bedside. “The fellows have become quite adept at identifying when a patient has cytokine storm [and] actually does need the biologic,” says Dr. Torralba. “With the attending’s supervision, [the fellows are] in charge of coordinating with the pharmacy how to get the biologic the same day—within hours of us making a recommendation.”

Some hospitalized patients have improved enough to return home. “The fellows and I are now seeing [discharged] patients in our rheumatology clinics as COVID-19 cytokine storm follow-up patients,” concludes Dr. Torralba.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Catherine Kolonko is a medical writer based in Oregon.

Page: 1 2 | Single Page
Share: 

Filed under:Biologics/DMARDsDrug Updates Tagged with:BiologicscoronavirusCOVID-19cytokine storm syndromeCytokinesmacrophage activation syndrome

Related Articles

    Tips for Implementing Ultrasound Training in Rheumatology Fellowships

    February 13, 2020

    ATLANTA—Point-of-care ultrasound education mainly has occurred at the undergraduate level at U.S. medical schools, but rheumatology fellowship training programs are rapidly catching up and integrating it into their curricula, according to two program directors who reviewed the state of rheumatology ultrasound education, including potential barriers to its implementation, on Nov. 12 at the 2019 ACR/ARP…

    Investigation Continues on Repurposed Rheumatology Therapies for COVID-19 Cytokine Storm

    November 14, 2020

    Roberto Caricchio, MD, discusses what trials of repurposed rheumatology drugs to treat COVID-19 cytokine storm have shown so far.

    The Many Facets of COVID-19: Experts Address Basic & Clinical Research Concepts in the COVID-19 Era

    November 23, 2021

    New concepts in autoimmunity & immunology are being discovered daily in research being conducted to understand the SARS-CoV-2 virus and its implications for rheumatology & all fields of medicine. Here are some insights shared by experts during day 1 of the Basic and Clinical Research Conference.

    Without Fear: Psychological Safety for Learners & Patients

    June 18, 2022

    Constructing a safe space for reporting errors is important & enables medical trainees to grow, making them better learners and scholars, and faculty members and patients to express their concerns. During a session at the 2022 ACR Education Exchange, Karina Torralba, MD, MACM, RhMSUS, provided insights into how to manage the barriers to fostering such a workplace culture.

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences